These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 28779302

  • 1. Skeletal complications of rheumatoid arthritis.
    Heinlen L, Humphrey MB.
    Osteoporos Int; 2017 Oct; 28(10):2801-2812. PubMed ID: 28779302
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Rheumatoid arthritis and bone -periarticular and systemic bone loss-].
    Ono K, Ohashi S, Tanaka S.
    Clin Calcium; 2013 Feb; 23(2):249-55. PubMed ID: 23354093
    [Abstract] [Full Text] [Related]

  • 4. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic intervention of rheumatoid arthritis bone loss].
    Ono K, Ohashi S, Tanaka S.
    Clin Calcium; 2013 Sep; 23(9):1345-52. PubMed ID: 23999372
    [Abstract] [Full Text] [Related]

  • 5. Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture.
    Ochi K, Inoue E, Furuya T, Ikari K, Toyama Y, Taniguchi A, Yamanaka H, Momohara S.
    Osteoporos Int; 2015 Mar; 26(3):961-8. PubMed ID: 25294026
    [Abstract] [Full Text] [Related]

  • 6. Biologic therapies and bone loss in rheumatoid arthritis.
    Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, Uña CR, Adachi JD, Lems WF, Cooper C, Lane NE, IOF Chronic Inflammation and Bone Structure (CIBS) Working Group.
    Osteoporos Int; 2017 Feb; 28(2):429-446. PubMed ID: 27796445
    [Abstract] [Full Text] [Related]

  • 7. Osteoporosis in inflammatory joint diseases.
    Roux C.
    Osteoporos Int; 2011 Feb; 22(2):421-33. PubMed ID: 20552328
    [Abstract] [Full Text] [Related]

  • 8. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Anno S, Koike T.
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [Abstract] [Full Text] [Related]

  • 9. [Rheumatoid arthritis and osteoporosis: trends in their treatments].
    Tanaka Y.
    Nihon Rinsho; 2006 Dec; 64(12):2359-66. PubMed ID: 17154104
    [Abstract] [Full Text] [Related]

  • 10. Can bone loss in rheumatoid arthritis be prevented?
    Vis M, Güler-Yüksel M, Lems WF.
    Osteoporos Int; 2013 Oct; 24(10):2541-53. PubMed ID: 23775419
    [Abstract] [Full Text] [Related]

  • 11. Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention.
    Raterman HG, Bultink IE, Lems WF.
    Expert Opin Pharmacother; 2020 Oct; 21(14):1725-1737. PubMed ID: 32605401
    [Abstract] [Full Text] [Related]

  • 12. Prescription for antiresorptive therapy in Mexican patients with rheumatoid arthritis: is it time to reevaluate the strategies for osteoporosis prevention?
    Gamez-Nava JI, Zavaleta-Muñiz SA, Vazquez-Villegas ML, Vega-Lopez A, Rodriguez-Jimenez NA, Olivas-Flores EM, Gonzalez-Montoya NG, Corona-Sanchez EG, Rocha-Muñoz AD, Martinez-Corral ME, Martin-Márquez BT, Vazquez-Del Mercado M, Muñoz-Valle JF, Cardona-Muñoz EG, Celis-De La Rosa A, Cabrera-Pivaral C, Gonzalez-Lopez L.
    Rheumatol Int; 2013 Jan; 33(1):145-50. PubMed ID: 22238026
    [Abstract] [Full Text] [Related]

  • 13. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.].
    Tanaka Y.
    Clin Calcium; 2018 Jan; 28(5):630-636. PubMed ID: 29731457
    [Abstract] [Full Text] [Related]

  • 14. [Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis].
    Suzuki Y, Wakabayashi T.
    Clin Calcium; 2015 Dec; 25(12):1825-34. PubMed ID: 26608858
    [Abstract] [Full Text] [Related]

  • 15. [Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment].
    Tanaka Y.
    Clin Calcium; 2010 May; 20(5):735-42. PubMed ID: 20445285
    [Abstract] [Full Text] [Related]

  • 16. Osteoporosis in rheumatoid arthritis.
    Dequeker J, Maenaut K, Verwilghen J, Westhovens R.
    Clin Exp Rheumatol; 1995 May; 13 Suppl 12():S21-6. PubMed ID: 8846540
    [Abstract] [Full Text] [Related]

  • 17. [Local and systemic bone effects of rheumatoid arthritis].
    Rauner M, Hofbauer LC, Aringer M.
    Z Rheumatol; 2012 Dec; 71(10):869-73. PubMed ID: 22806699
    [Abstract] [Full Text] [Related]

  • 18. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG.
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [Abstract] [Full Text] [Related]

  • 19. Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
    Lee JH, Cho SK, Han M, Kim D, Bae SC, Sung YK.
    Korean J Intern Med; 2014 Jul; 29(4):509-15. PubMed ID: 25045299
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids.
    Ghazi M, Kolta S, Briot K, Fechtenbaum J, Paternotte S, Roux C.
    Osteoporos Int; 2012 Feb; 23(2):581-7. PubMed ID: 21350894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.